Drug or treatment

CAPMATINIB clinical trials

As of November 12, 2026, Find a Trial lists 3 clinical trials of CAPMATINIB that are recruiting, at sites in 3 countries (most in United Kingdom (1), South Korea (1), United States (1)). By phase: Phase 2/3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Capmatinib treatment for adults with cancers having MET gene changes Phase 2/3 Belfast and 16 other locations Recruiting May 23, 2025
Observational study on the use of Tabrecta® for lung cancer in South Korea — Daegu, Dalseo gu and 9 other locations Recruiting Jan 30, 2023
Comparing targeted drug combinations for advanced lung cancer with specific gene changes Phase 2 Daphne, Alabama and 453 other locations Recruiting Dec 8, 2022

All recruiting trials (3)

Quick answers

How many clinical trials of CAPMATINIB are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United Kingdom (1 trial), South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.